Untangling Addiction — Execution
Supports United Kingdom addiction science projects targeting substance use mechanisms and treatment translation.
Untangling Addiction is a $50 million Wellcome Leap program launched in 2025 to accelerate prevention and treatment of substance use disorder. The program sets three specific technical goals: developing predictive risk assessment tools with a minimum precision of 85 percent, creating quantitative methods to track recovery over time, and identifying novel therapeutic interventions. Wellcome Leap de…
Substance use disorder prevention and treatment research delivering predictive risk tools with at least 85% precision, quantitative recovery monitoring, and novel therapeutic interventions.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Application Form Example: Fields, Attachments, and Portal Answers
See a grant application form example with common fields, portal answer patterns, attachment logic, and mistakes to avoid.
DocumentsLogic Model Template for Grant Proposals
Use this grant logic model template to connect inputs, activities, outputs, outcomes, assumptions, evaluation, and budget logic before writing a proposal.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
ARPA-H Program ISOs (topic-specific)
🇺🇸ARPA-H · United States
Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.